Glueck, Charles J.

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 865

Metabolic Syndrome in Childhood Predicts Adult Metabolic Syndrome and Type 2 Diabetes Mellitus 25 to 30 Years Later

Morrison, J. A., Friedman, L. A., Wang, P., & Glueck, C. J. (2008) · The Journal of Pediatrics

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 649

Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics

Glueck, C. J., & Goldenberg, N. (2019) · Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 442

Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30

Glueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T. R., Weber, K., Illig, E., Streicher, P., Sieve-Smith, L., Tracy, T. M., Lang, J. E., et al. (2001) · Metabolism

Pharmacology and Obesity TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 188

Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2

Breslow, J. L., Zannis, V. I., SanGiacomo, T. R., Third, J. L., Tracy, T., & Glueck, C. J. (1982) · Journal of Lipid Research

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 174

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

Glueck, C. J., Bornovali, S., Pranikoff, J., Goldenberg, N., Dharashivkar, S., & Wang, P. (2004) · Diabetic Medicine

Ovarian function and disordersPregnancy and preeclampsia studies

Cited by 115

Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy

Baillargeon, J., Urban, R. J., Morgentaler, A., Glueck, C. J., Baillargeon, G., Sharma, G., & Kuo, Y.-F. (2015) · Mayo Clinic Proceedings

Venous Thromboembolism Diagnosis and ManagementHormonal and reproductive studies

Cited by 107

Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy

Glueck, C. J., Dharashivkar, S., Wang, P., Zhu, B., Gartside, P. S., Tracy, T., & Sieve, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 99

Rosuvastatin 5 and 10 mg/d: A pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach ldl cholesterol goals with nonstatin lipid-lowering therapies

Glueck, C. J., Aregawi, D., Agloria, M., Khalil, Q., Winiarska, M., Munjal, J., Gogineni, S., & Wang, P. (2006) · Clinical Therapeutics

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 73

Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents

Glueck, C. J., Morrison, J. A., Friedman, L. A., Goldenberg, N., Stroop, D. M., & Wang, P. (2006) · Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 65

Sex Hormone-Binding Globulin, Oligomenorrhea, Polycystic Ovary Syndrome, and Childhood Insulin at Age 14 Years Predict Metabolic Syndrome and Class III Obesity at Age 24 Years

Glueck, C. J., Morrison, J. A., Daniels, S., Wang, P., & Stroop, D. (2011) · The Journal of Pediatrics

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 63

Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome

Glueck, C. J., Salehi, M., Sieve, L., & Wang, P. (2006) · The Journal of Pediatrics

Pregnancy and Medication ImpactOvarian function and disorders

Cited by 58

Metformin before and during pregnancy and lactation in polycystic ovary syndrome

Glueck, C. J., & Wang, P. (2007) · Expert Opinion on Drug Safety

Pregnancy and Medication ImpactOvarian function and disorders

Cited by 36